188 related articles for article (PubMed ID: 15598989)
1. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes.
Chappel JA; Hollingdale MR; Kang AS
Hum Antibodies; 2004; 13(3):91-6. PubMed ID: 15598989
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen.
Fidock DA; Pasquetto V; Gras H; Badell E; Eling W; Ballou WR; Belghiti J; Tartar A; Druilhe P
Eur J Immunol; 1997 Oct; 27(10):2502-13. PubMed ID: 9368603
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.
Dutta S; Haynes JD; Barbosa A; Ware LA; Snavely JD; Moch JK; Thomas AW; Lanar DE
Infect Immun; 2005 Apr; 73(4):2116-22. PubMed ID: 15784553
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
[TBL] [Abstract][Full Text] [Related]
6. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
Nguyen TV; Sacci JB; de la Vega P; John CC; James AA; Kang AS
Malar J; 2009 Oct; 8():235. PubMed ID: 19852802
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Plasmodium sporozoite neutralization assay (TSNA).
Kumar KA; Oliveira GA; Edelman R; Nardin E; Nussenzweig V
J Immunol Methods; 2004 Sep; 292(1-2):157-64. PubMed ID: 15350520
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation.
Okitsu SL; Kienzl U; Moehle K; Silvie O; Peduzzi E; Mueller MS; Sauerwein RW; Matile H; Zurbriggen R; Mazier D; Robinson JA; Pluschke G
Chem Biol; 2007 May; 14(5):577-87. PubMed ID: 17524988
[TBL] [Abstract][Full Text] [Related]
10. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum in parasite-host cell interactions.
Müller HM; Scarselli E; Crisanti A
Parassitologia; 1993 Jul; 35 Suppl():69-72. PubMed ID: 8233617
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites.
Zhang D; Pan W
Infect Immun; 2005 Oct; 73(10):6530-6. PubMed ID: 16177327
[TBL] [Abstract][Full Text] [Related]
13. Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes.
Puentes A; García J; Vera R; López R; Suarez J; Rodríguez L; Curtidor H; Ocampo M; Tovar D; Forero M; Bermudez A; Cortes J; Urquiza M; Patarroyo ME
Vaccine; 2004 Mar; 22(9-10):1150-6. PubMed ID: 15003642
[TBL] [Abstract][Full Text] [Related]
14. Towards a synthetic malaria vaccine: cyclization of a peptide eliminates the production of parasite-unreactive antibody.
Etlinger HM; Trzeciak A
Philos Trans R Soc Lond B Biol Sci; 1993 Apr; 340(1291):69-72. PubMed ID: 8099745
[TBL] [Abstract][Full Text] [Related]
15. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
Etlinger HM; Felix AM; Gillessen D; Heimer EP; Just M; Pink JR; Sinigaglia F; Stürchler D; Takacs B; Trzeciak A
J Immunol; 1988 Jan; 140(2):626-33. PubMed ID: 3275719
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.
Espinosa DA; Gutierrez GM; Rojas-López M; Noe AR; Shi L; Tse SW; Sinnis P; Zavala F
J Infect Dis; 2015 Oct; 212(7):1111-9. PubMed ID: 25762791
[TBL] [Abstract][Full Text] [Related]
17. Pf 155, a candidate for a blood stage vaccine in Plasmodium falciparum malaria.
Berzins K; Perlmann H; Udomsangpetch R; Wåhlin B; Wahlgren M; Troye-Blomberg M; Carlsson J; Björkman A; Perlmann P
Dev Biol Stand; 1985; 62():99-106. PubMed ID: 3914427
[TBL] [Abstract][Full Text] [Related]
18. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Polhemus ME; Magill AJ; Cummings JF; Kester KE; Ockenhouse CF; Lanar DE; Dutta S; Barbosa A; Soisson L; Diggs CL; Robinson SA; Haynes JD; Stewart VA; Ware LA; Brando C; Krzych U; Bowden RA; Cohen JD; Dubois MC; Ofori-Anyinam O; De-Kock E; Ballou WR; Heppner DG
Vaccine; 2007 May; 25(21):4203-12. PubMed ID: 17442466
[TBL] [Abstract][Full Text] [Related]
19. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: production of human antibodies specific for the MSP-3 protein in the Hu-SPL-SCID mouse.
Bouharoun-Tayoun H; Noun G; Druilhe P; Nakhlé C; Haddad N; Chamat S
Exp Parasitol; 2004; 108(1-2):47-52. PubMed ID: 15491548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
